EDGAR Filing Documents for 0001493152-19-014109

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001493152-19-014109

Filing Date

2019-09-13

Accepted

2019-09-13 17:20:11

Documents

Period of Report

2019-09-11

Document Format Files

Seq	Description	Document	Type	Size
1		ownership.html	4
1		ownership.xml	4	3085
	Complete submission text file	0001493152-19-014109.txt		4831

Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008

Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390

Lineage Cell Therapeutics, Inc. (Reporting) CIK: 0000876343 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 191093239
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501

Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515

OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances